[ad_1]
The German Health Ministry announced that the use of the coronavirus (covid-19) vaccine developed by Oxford / AstraZeneca has been suspended on the recommendation of the German research institution Paul Ehrlich Institute.
According to the DHA news, in a statement made by the German Ministry of Health, it was announced that the use of the coronavirus vaccine developed by Oxford / AstraZeneca was suspended. The decision was claimed to have been made on the recommendation of the German research institution Paul Ehrlich Institute.
In Italy, AstraZeneca announced that it has temporarily stopped the use of the Kovid-19 vaccine developed by the company.
French President Emmanuel Macron announced that they have suspended the use of the Kovid-19 vaccine developed by AstraZeneca until noon tomorrow.
ASTRAZENECA SUSPENSED IN EUROPE
Many countries in Europe, including Norway, Iceland, Denmark, the Netherlands, Bulgaria, Austria, Estonia, Latvia, Luxembourg, and Lithuania, have decided to discontinue the use of AstraZeneca. Germany was added to these countries. In England, the vaccine is still used.
ASTRAZENECA: NO PIHTI RISK
In the statement made by AstraZeneca, it was stated that there was no evidence of the risk of blood clotting induced by the coronavirus vaccine. “Analysis of our safety data from more than 10 million records showed no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any specific age group, gender, community, or country with the AstraZeneca Covid-19 vaccine.” the statement said. . The statement also read: “In fact, the observed number of such events is significantly lower than expected in vaccinated compared to the general population.”
EUROPEAN PHARMACEUTICAL AGENCY: BENEFITS OF ASTRAZENECA MORE THAN RISKS
According to the AA news, the European Medicines Agency (EMA), the European Union (EU) drug regulator, reported that the benefits of the Kovid-19 AstraZeneca vaccine, which was detained in some European countries on the grounds that causes blood clotting, outweighing the risks.
The EMA, which met to determine opinion after the use of the Kovid-19 vaccine developed by AstraZeneca was discontinued in some countries, made a statement on the matter.
In the statement, it was reported that the AstraZeneca vaccine, which was suspended as a precaution in some European countries such as France, Germany, Italy and the Netherlands, continued to be tested on the grounds that it could cause blood clotting and death.
Stating that coagulation cases are expressed in very small numbers, “the number of cases of vascular occlusion as a result of coagulation in vaccinated people does not appear to be higher than that found in the general population.” the declaration took place.
It was indicated that investigations will continue to determine if the vaccine caused the problems in the cases in question and that a conclusion would be reached on Thursday in light of the information obtained.
“As the review continues, the EMA maintains the view that the benefit of the AstraZeneca vaccine in preventing Covid-19 in relation to hospitalizations and deaths outweighs the risks of side effects,” the statement said. statement was included.
Experts from the World Health Organization (WHO) also said: “There are no documented deaths associated with the Kovid-19 vaccines after more than 300 million doses of different vaccines have been administered worldwide so far.” He explained and asked people using AstraZeneca and other vaccines not to “panic.”
In European countries, 22 of the 3 million people who received the AstraZeneca vaccine as of March 9 had clotting.
CLICK HERE TO SEE THE BREAKING NEWS FROM THE CORONAVIRUS!
